4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001209191-21-007635
Chief Medical Officer sold 1,813 shares at $28.91 ($52,414)
From the SEC's structured data for this filing
Trades in this filing
Rosenberg Noah L. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-03 | Sale : show line 1 in the form | −1,250 | $28.91 | $36,138 | 44,657 | D |
| 2021-02-03 | Sale : show line 2 in the form | −563 | $28.91 | $16,276 | 44,094 | D |
| Open-market sales · 1,813 sh · avg $28.91 · $52,414 | ||||||
Loading xslF345X03/doc4.xml…